Publicaciones (58) Publicaciones en las que ha participado algún/a investigador/a

2019

  1. Fluoxetine oral treatment discloses 5-HT 1D receptor as vagoinhibitor of the cardiac cholinergic neurotransmission in rat

    Canadian Journal of Physiology and Pharmacology, Vol. 97, Núm. 2, pp. 90-98

  2. Hypertension exhibits 5-HT 4 receptor as a modulator of sympathetic neurotransmission in the rat mesenteric vasculature

    Hypertension Research, Vol. 42, Núm. 5, pp. 618-627

  3. Angiogenic response in an in vitro model of dog microvascular endothelial cells stimulated with antigenic extracts from Dirofilaria immitis adult worms

    Parasites and Vectors, Vol. 12, Núm. 1

  4. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses

    The Lancet, Vol. 393, Núm. 10174, pp. 899-909

  5. Associations between sensorimotor gating mechanisms and athletic performance in a variety of physical conditioning tests

    European Journal of Applied Physiology, Vol. 119, Núm. 4, pp. 921-932

  6. Barley-ß-glucans reduce systemic inflammation, renal injury and aortic calcification through ADAM17 and neutral-sphingomyelinase2 inhibition

    Scientific Reports, Vol. 9, Núm. 1

  7. Biological Background of Resistance to Current Standards of Care in Multiple Myeloma

    Cells, Vol. 8, Núm. 11

  8. Biomarcadores de nefrotoxicidad capaces de identificar pacientes oncológicos en riesgo de desarrollar daño renal

    Farmajournal, Vol. 4, Núm. 2, pp. 41-50

  9. Biopiracy versus One-World Medicine–From colonial relicts to global collaborative concepts

    Phytomedicine, Vol. 53, pp. 319-331

  10. Cardiotrophin-1 opposes renal fibrosis in mice: Potential prevention of chronic kidney disease

    Acta Physiologica, Vol. 226, Núm. 2

  11. Causes of hOCT1-Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor-Selective Gene Therapy

    Hepatology, Vol. 70, Núm. 4, pp. 1246-1261

  12. Chemosensitization of hepatocellular carcinoma cells to sorafenib by β-caryophyllene oxide-induced inhibition of ABC export pumps

    Archives of Toxicology, Vol. 93, Núm. 3, pp. 623-634

  13. Defects in memory B-cell and plasma cell subsets expressing different immunoglobulin-subclasses in patients with CVID and immunoglobulin subclass deficiencies

    Journal of Allergy and Clinical Immunology, Vol. 144, Núm. 3, pp. 809-824

  14. Development and characterization of mouse monoclonal antibodies to eight human complement components: Analysis of reactivity with orthologs of nine mammalian genera

    Comparative Immunology, Microbiology and Infectious Diseases, Vol. 62, pp. 7-12

  15. Diagnostic and prognostic biomarkers in cholangiocarcinoma

    Liver International, Vol. 39, Núm. S1, pp. 108-122

  16. Dihydropyrimidine-2-thiones as Eg5 inhibitors and L-type calcium channel blockers: Potential antitumour dual agents

    MedChemComm, Vol. 10, Núm. 9, pp. 1589-1598

  17. Drug-induced thrombotic microangiopathy during maintenance treatment in a patient with multiple myeloma

    HemaSphere, Vol. 3, Núm. 3

  18. Effect of hemodynamic changes in plasma propofol concentrations associated with knee-chest position in spinal surgery: A prospective study

    Anesthesiology and Pain Medicine, Vol. 9, Núm. 5

  19. Effectiveness of a mitigation measure for the lesser kestrel (Falco naumanni) in wind farms in Spain

    Journal of Environmental Management, Vol. 231, pp. 919-925

  20. Epigenetic events involved in organic cation transporter 1-dependent impaired response of hepatocellular carcinoma to sorafenib

    British Journal of Pharmacology, Vol. 176, Núm. 6, pp. 787-800